Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 14, 2023
Discovery & Translation
E3 ligase pathways for liver diseases, a trypanosome RPA1 inhibitor and more
New targets and compounds from BioCentury’s Distillery
BioCentury | May 17, 2019
Product Development
Pushing China to the forefront: When a first-in-China regulatory strategy makes sense
How patient prevalence and market access could encourage companies to launch their drugs first in China.
BioCentury | Mar 25, 2019
Distillery Therapeutics
IL-17RD or inhibition of ZEB1 to sensitize lung cancer to MEK inhibition
BioCentury | Nov 9, 2018
Tools & Techniques
HitGen’s DNA for small molecules
How HitGen is amplifying DNA-encoded library-based drug design
Items per page:
1 - 10 of 45